Core Scientific (CORZ) EBT (2020 - 2026)

Core Scientific has disclosed EBT across 7 years of filings, most recently posting -$1.2 billion for Q2 2026.

• In Q2 2026, EBT fell 23.14% year-over-year to -$1.2 billion; the TTM figure through Jun 2026 stood at -$1.4 billion (down 29.09% YoY), while the FY2025 annual figure was -$288.0 million, up 79.96% from the prior year.
• EBT came in at -$1.2 billion for Q2 2026 at Core Scientific, down from -$346.6 million in the prior quarter.
• In the past five years, EBT ranged from a high of $576.5 million in Q1 2025 to a low of -$1.2 billion in Q2 2026.
• Average EBT over 5 years is -$313.0 million, with a median of -$318.7 million recorded in 2024.
• Year-over-year, EBT slumped 25965.69% in 2022 and jumped 74359.51% in 2024.
• Over 5 years, EBT stood at -$456.3 million in 2022, then jumped by 57.19% to -$195.4 million in 2023, then sank by 48.84% to -$290.8 million in 2024, then jumped by 174.3% to $216.1 million in 2025, then slumped by 633.85% to -$1.2 billion in 2026.
• Per Business Quant data, the three most recent EBT figures were -$1.2 billion in Q2 2026, -$346.6 million in Q1 2026, and $216.1 million in Q4 2025.